Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
SEC Accession No. 0001193805-23-000097
Filing Date
2023-02-08
Accepted
2023-02-08 16:22:37
Documents
6

Document Format Files

Seq Description Document Type Size
1 e618243_f6ef-tpi.htm F-6EF 66441
2 e618243_ex99-a.htm EX-99.(A) 467892
3 e618243_ex99-d.htm EX-99.(D) 6272
4 e618243_ex99-e.htm EX-99.(E) 3896
5 GRAPHIC logo.jpg GRAPHIC 9864
6 GRAPHIC image.jpg GRAPHIC 11940
  Complete submission text file 0001193805-23-000097.txt   576304
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-6EF | Act: 33 | File No.: 333-269640 | Film No.: 23599365
SIC: 2834 Pharmaceutical Preparations

Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

EIN.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6EF